Technology
Health
Pharmaceutical

Eyenovia

$4.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.14%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Eyenovia and other stocks, options, ETFs, and crypto commission-free!

About

Eyenovia, Inc. Common Stock, also called Eyenovia, is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. Read More The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The company was founded on March 12, 2014 and is headquartered in New York, NY.

Employees
24
Headquarters
New York, New York
Founded
2014
Market Cap
52.52M
Price-Earnings Ratio
Dividend Yield
Average Volume
91.52K
High Today
$4.61
Low Today
$4.02
Open Price
$4.44
Volume
65.59K
52 Week High
$7.81
52 Week Low
$2.40

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Research And Development
Therapy
2018 IPO

Earnings

-$0.60
-$0.54
-$0.49
-$0.43
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 14, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.